Skip to Main Navigation

Documents & Reports

Showing 1 - 9 of 9 results | Display results in sets of 10 | 20 | 50

Download:
No Records Found. Change your search criteria and try again. I cannot find the document I am looking for.

  • An overview of medical device policy and regulation (English)

    Medical devices, ranging from a simple disposable syringe to a high end PET/CT scanner, pose significant regulatory, planning and management challenges for client countries. Michael Cheng provides a practical...

    Document Type: Brief Report No.: 38819 Document Date: February 1, 2007 Disclosure Status: Disclosed Author: Cheng,Michael Y.

  • Pharmaceuticals: cost containment, pricing, reimbursement (English)

    In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights...

    Document Type: Brief Report No.: 35560 Document Date: August 1, 2005 Disclosure Status: Disclosed Author: Lakshminarayanan, Rama [editor],Seiter,Andreas

  • Pharmaceuticals : quality assurance in the distribution chain (English)

    Many health projects rely on a regular supply of quality pharmaceuticals. Here is a practical guide how to assure drug quality along the distribution chain and win the fight against substandard and counterfeit...

    Document Type: Brief Report No.: 32932 Document Date: July 1, 2005 Disclosure Status: Disclosed Author: Lakshminarayanan, Rama [editor],Seiter,Andreas


  • Pharmaceuticals: drug regulation in low and middle income countries (English)

    Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall...

    Document Type: Brief Report No.: 32194 Document Date: April 1, 2005 Disclosure Status: Disclosed Author: Seiter,Andreas,de Beyer, Joy [editor]

  • Pharmaceuticals: local manufacturing (English)

    What factors must be weighed when deciding whether to promote local manufacturing of pharmaceuticals in developing countries? Andreas Seiter's note summarizes pros, cons and key issues. Pharmaceuticals...

    Document Type: Brief Report No.: 32193 Document Date: March 1, 2005 Disclosure Status: Disclosed Author: Seiter,Andreas,de Beyer, Joy [editor]

  • Pharmaceutical: counterfeits, substandard drugs and drug diversion (English)

    Counterfeit and substandard drugs jeopardize health and waste money. Andreas Seiter reviews dimensions of the problem and contributing factors, and how countries can ensure drug quality. Pharmaceutical...

    Document Type: Brief Report No.: 32192 Document Date: March 1, 2005 Disclosure Status: Disclosed Author: Seiter,Andreas

  • PRSPs, immunization targets, and equity : focus on Africa (English)

    In Africa many Poverty Reduction Strategy Paper (PRSPs) include immunization coverage targets, and debt relief often provides additional funds to help achieve them. Joe Naimoli looks at some implications...

    Document Type: Brief Report No.: 32191 Document Date: February 1, 2005 Disclosure Status: Disclosed Author: Challa,Shilpa,Naimoli,Joseph Francis,Tanuku,Deepti